These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 29623648)

  • 1. Osteoporosis-Related Fractures in HIV-Infected Patients Receiving Long-Term Tenofovir Disoproxil Fumarate: An Observational Cohort Study.
    Komatsu A; Ikeda A; Kikuchi A; Minami C; Tan M; Matsushita S
    Drug Saf; 2018 Sep; 41(9):843-848. PubMed ID: 29623648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential skeletal impact of tenofovir disoproxil fumarate in young versus old HIV-infected adults.
    Grant PM; Kitch D; McComsey GA; Tierney C; Ha B; Brown TT
    HIV Clin Trials; 2015; 16(2):66-71. PubMed ID: 25872972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-World Assessment of Renal and Bone Safety among Patients with HIV Infection Exposed to Tenofovir Disoproxil Fumarate-Containing Single-Tablet Regimens.
    Nkhoma ET; Rosenblatt L; Myers J; Villasis-Keever A; Coumbis J
    PLoS One; 2016; 11(12):e0166982. PubMed ID: 27941989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal Toxicity of Concomitant Exposure to Tenofovir and Inhibitors of Tenofovir's Renal Efflux Transporters in Patients Infected With HIV Type 1.
    Rokx C; Alshangi H; Verbon A; Zietse R; Hoorn EJ; Rijnders BJ
    J Infect Dis; 2016 Feb; 213(4):561-8. PubMed ID: 26401025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tenofovir and bone health.
    Grant PM; Cotter AG
    Curr Opin HIV AIDS; 2016 May; 11(3):326-32. PubMed ID: 26859637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV Infection, Tenofovir, and Urine α1-Microglobulin: A Cross-sectional Analysis in the Multicenter AIDS Cohort Study.
    Jotwani V; Scherzer R; Estrella MM; Jacobson LP; Witt MD; Palella FJ; Macatangay B; Bennett M; Parikh CR; Ix JH; Shlipak MG
    Am J Kidney Dis; 2016 Oct; 68(4):571-581. PubMed ID: 27287300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of tenofovir disoproxil fumarate exposure with chronic kidney disease and osteoporotic fracture in US veterans with HIV.
    Sutton SS; Magagnoli J; Hardin JW; Hsu LI; Beaubrun A; Majethia S; Cummings TH
    Curr Med Res Opin; 2020 Oct; 36(10):1635-1642. PubMed ID: 32856940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary β2 microglobulin can predict tenofovir disoproxil fumarate-related renal dysfunction in HIV-1-infected patients who initiate tenofovir disoproxil fumarate-containing antiretroviral therapy.
    Nishijima T; Kurosawa T; Tanaka N; Kawasaki Y; Kikuchi Y; Oka S; Gatanaga H
    AIDS; 2016 Jun; 30(10):1563-71. PubMed ID: 26919734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations between vitamin D metabolites, antiretroviral therapy and bone mineral density in people with HIV.
    Klassen KM; Kimlin MG; Fairley CK; Emery S; Anderson PH; Ebeling PR;
    Osteoporos Int; 2016 May; 27(5):1737-45. PubMed ID: 26659069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and significance of proximal renal tubular abnormalities in HIV-infected patients receiving tenofovir.
    Casado JL; Bañón S; Santiuste C; Serna J; Guzman P; Tenorio M; Liaño F; del Rey JM
    AIDS; 2016 Jan; 30(2):231-9. PubMed ID: 26684820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Antiretroviral Drugs on Fracture Risk in HIV-Infected Individuals: A Case-Control Study Nested Within the French Hospital Database on HIV (FHDH-ANRS CO4).
    Costagliola D; Potard V; Lang S; Abgrall S; Duvivier C; Fischer H; Joly V; Lacombe JM; Valantin MA; Mary-Krause M; Rozenberg S
    J Acquir Immune Defic Syndr; 2019 Feb; 80(2):214-223. PubMed ID: 30422911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone mineral density changes among people living with HIV who have started with TDF-containing regimen: A five-year prospective study.
    Han WM; Wattanachanya L; Apornpong T; Jantrapakde J; Avihingsanon A; Kerr SJ; Teeratakulpisarn N; Jadwattanakul T; Chaiwatanarat T; Buranasupkajorn P; Ramautarsing R; Phanuphak N; Sunthornyothin S; Ruxrungtham K; Phanuphak P;
    PLoS One; 2020; 15(3):e0230368. PubMed ID: 32210458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with fractures in HIV-infected persons: which factors matter?
    Gedmintas L; Wright EA; Dong Y; Lehmann E; Katz JN; Solomon DH; Losina E
    Osteoporos Int; 2017 Jan; 28(1):239-244. PubMed ID: 27421978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of oral tenofovir disoproxil fumarate-based pre-exposure prophylaxis for HIV prevention.
    Mugwanya KK; Baeten JM
    Expert Opin Drug Saf; 2016; 15(2):265-73. PubMed ID: 26634852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy, safety and pharmacokinetics of tenofovir disoproxil fumarate in virologic-suppressed HIV-infected children using weight-band dosing.
    Aurpibul L; Cressey TR; Sricharoenchai S; Wittawatmongkol O; Sirisanthana V; Phongsamart W; Sudjaritruk T; Chokephaibulkit K
    Pediatr Infect Dis J; 2015 Apr; 34(4):392-7. PubMed ID: 25760566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tenofovir disoproxil fumarate safety for women and their infants during pregnancy and breastfeeding.
    Mofenson LM; Baggaley RC; Mameletzis I
    AIDS; 2017 Jan; 31(2):213-232. PubMed ID: 27831952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal safety of lithium in HIV-infected patients established on tenofovir disoproxil fumarate containing antiretroviral therapy: analysis from a randomized placebo-controlled trial.
    Decloedt EH; Lesosky M; Maartens G; Joska JA
    AIDS Res Ther; 2017 Feb; 14(1):6. PubMed ID: 28160772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of tenofovir disoproxil fumarate on bone mineral density: a systematic review and meta-analysis.
    Baranek B; Wang S; Cheung AM; Mishra S; Tan DH
    Antivir Ther; 2020; 25(1):21-32. PubMed ID: 32077867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiretrovirals, Fractures, and Osteonecrosis in a Large International HIV Cohort.
    Borges ÁH; Hoy J; Florence E; Sedlacek D; Stellbrink HJ; Uzdaviniene V; Tomazic J; Gargalianos-Kakolyris P; Schmid P; Orkin C; Pedersen C; Leen C; Pradier C; Mulcahy F; Ridolfo AL; Staub T; Maltez F; Weber R; Flamholc L; Kyselyova G; Lundgren JD; Mocroft A;
    Clin Infect Dis; 2017 May; 64(10):1413-1421. PubMed ID: 28329090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fractures Related to Tenofovir: A Case/Noncase Study in the European Pharmacovigilance Database.
    García MG; Larrinaga-Torrontegui U; Eduardo Martinez E; Lertxundi U; Palacios-Zabalza I; Aguirre C
    Am J Ther; 2019; 26(5):e589-e592. PubMed ID: 29324463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.